Hantavirus Vaccine UK 2026: What You Actually Need to Know

The MV Hondius cluster has put hantavirus back in UK headlines — but the vaccine story is still early.

In May 2026, a cluster of hantavirus cases linked to the MV Hondius cruise ship, reported by the World Health Organization (WHO DON599), made headlines. With UK passengers among those affected, the UK Health Security Agency (UKHSA) began monitoring the situation, prompting many to ask: what is this virus, is there a vaccine, and should we be worried? This explainer cuts through the noise.

We’ll look at what hantavirus is, the reality behind vaccine development, what the UK authorities are saying, and what your actual risk level is.

What hantavirus actually is

Often mistaken for something new, hantavirus is a family of viruses long carried by rodents—primarily rats and field mice. Humans typically become infected not through bites, but by inhaling air contaminated with dust from dried rodent urine, droppings, or saliva. This can happen in barns, sheds, or cabins where rodents live. According to the UKHSA, the virus isn’t transmitted between people.

Two main illnesses define the threat. In the Americas, it causes hantavirus pulmonary syndrome (HPS), a severe respiratory disease with a high fatality rate of around 30–40%. In Asia and Europe, including parts of Scandinavia, it more commonly causes haemorrhagic fever with renal syndrome (HFRS), which affects the kidneys, with severity varying by the specific viral strain.

Symptoms typically appear one to six weeks after exposure. Early signs are flu-like: fever, fatigue, muscle aches, and a headache. As the illness progresses, it can lead to serious breathing difficulties or kidney failure, depending on the strain contracted. There is no specific antiviral treatment. Medical care focuses on supporting the patient’s breathing and organ function while their body fights the virus. In the UK, the disease is extremely rare, with only occasional imported cases.

Why is hantavirus in UK headlines in May 2026?

The sudden surge in UK interest stems directly from the WHO’s May 2026 Disease Outbreak News report (DON599). It detailed a multi-country cluster of hantavirus cases epidemiologically linked to a voyage of the MV Hondius, an expedition cruise ship. The report confirmed that UK residents were among those affected.

This specific, international incident involving UK citizens is the sole reason for the spike in searches and news coverage. It’s important to frame this accurately: this was a contained outbreak linked to a specific exposure event, not evidence of hantavirus spreading within the UK. The UKHSA has been actively involved in the international response, monitoring contacts and providing guidance. However, the agency has stressed that the overall risk to the UK public from this cluster remains low. The virus is not endemic in British rodent populations in the way it is in parts of Asia or the Americas, making widespread transmission here highly unlikely.

Medical professionals are monitoring the situation, but the public risk is assessed as low.

Is there a hantavirus vaccine in the UK in 2026?

The straightforward answer is no. As of May 2026, no hantavirus vaccine is licensed for use in the UK or is available through the NHS. The disease is simply too rare in the UK to justify a routine vaccination programme.

However, the picture of vaccine development is changing. A significant collaboration between Moderna and the Korea University Vaccine Innovation Center, initiated in September 2023, is actively working on an mRNA hantavirus vaccine through Moderna’s mRNA Access Program. This partnership represents the most advanced candidate currently making headlines.

Early results are encouraging, but broad availability is still some way off. Reporting from Reuters and NBC News, citing independent experts, suggests it could be three to four more years before such a vaccine completes the necessary clinical trials and gains approval. It’s also worth noting that a separate vaccine, Hantavax, produced by Pasteur Korea, is licensed and used in South Korea. However, it is not authorised for use in the UK or the EU. The mRNA platform, proven during the COVID-19 pandemic, is what’s accelerating progress, allowing for faster, strain-specific vaccine design against this complex virus family.

What the Moderna Phase 1 actually showed

In early 2026, Moderna reported encouraging initial data from its Phase 1 clinical trial. The results indicated that the mRNA vaccine candidate was well-tolerated by participants, with no serious safety signals identified. It generated strong antibody responses across all dose levels tested.

You need to understand the scope of a Phase 1 trial: its primary goals are to assess safety and measure the initial immune response. It does not prove the vaccine can prevent the actual disease. Those efficacy questions are addressed in later, larger Phase 2 and 3 trials, which are the next steps in the lengthy development process.

How worried should UK adults actually be?

Public health advice is clear: concern should be proportionate to risk. For the vast majority of people in the UK, the risk of contracting hantavirus is extremely low. The virus is not circulating in our local wildlife, so everyday life does not pose an exposure risk. The 2026 cruise-ship cluster, while serious for those involved, was a specific and isolated incident. It is not a sign of wider transmission in the UK or on cruise ships generally.

For travellers, the advice is practical. The main protection in high-risk areas—such as rural parts of the Americas, or agricultural regions in Asia—is good hygiene to avoid contact with rodents. The UKHSA advises keeping food sealed and stored away, avoiding sweeping out dusty sheds or cabins without a damp cloth and protective mask, and never handling rodent carcasses.

Frequently Asked Questions

Is there a hantavirus vaccine available on the NHS in 2026?

No. As of May 2026, there is no hantavirus vaccine licensed for use in the UK. The NHS does not offer it, as the disease is considered very rare and not a significant public health threat within Britain. Vaccine development is ongoing internationally but remains in clinical trials.

How do you catch hantavirus?

You catch it primarily by breathing in dust contaminated with the urine, droppings, or saliva of infected rodents, usually rats and field mice. It is not spread from person to person. Activities like cleaning out sheds, barns, or cabins where rodents have lived can pose a risk in endemic areas.

What are the symptoms of hantavirus?

Initial symptoms, appearing 1 to 6 weeks after exposure, are flu-like: fever, severe muscle aches, fatigue, and headaches. Depending on the viral strain, it can then progress to cause serious breathing difficulties (hantavirus pulmonary syndrome) or kidney problems (haemorrhagic fever with renal syndrome).

Can the COVID vaccine cause hantavirus?

No. There is no scientific evidence or plausible mechanism for any COVID-19 vaccine to cause hantavirus. Claims linking them online have been thoroughly debunked by fact-checking organisations like Full Fact and Snopes. The two viruses are entirely unrelated.

Should I cancel a cruise booking because of hantavirus?

Based on current information from the WHO and UKHSA, cancelling a cruise due to hantavirus fear is not advised. The MV Hondius cluster was a rare event. Standard cruise ship hygiene and public health measures are designed to control a wide range of infectious diseases. Your overall risk of encountering hantavirus on a cruise remains exceptionally low.

This article is informational only and does not replace personalised advice from your GP, pharmacist, or another qualified healthcare professional.